Accomplished Senior Clinical Trial Manager with a proven track record at Novartis Pharmaceutical and Eliassen Group, adept in Clinical Trial Management and cross-functional team leadership. Excelled in ensuring regulatory compliance, enhancing trial efficiency, and managing budgets effectively. Mentored junior staff, fostering professional growth. Demonstrated expertise in vendor management and quality assurance, contributing to successful trial outcomes.
Immunology, Urticaria (Phases II, III), Infectious Disease/Vaccine, Coronavirus Disease, Respiratory Syncytial Virus (Phase III), Oncology, Acute Myeloid Leukemia (Phase II), Neurology, Migraine (Phases II/III), Infectious Disease, H1N1 Influenza, HIV (Phases II, III), Endocrinology, Diabetes Type 2 (Phase III), Dermatology, Atopic Dermatitis, Roseau (Phases II, III), Cardiovascular, Hypertension, Hypercholesterolemia (Phase III), Oncology, Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer (Phases II/III), Neuroscience, Bipolar Disorder, Schizophrenia, Attention Deficit Disorder, Pseudobulbar Affect, Alzheimer's Disease (Phases II, III), Respiratory, Chronic Obstructive Pulmonary Disease (COPD) (Phase III), Ophthalmology, Glaucoma, Diabetic Retinopathy, Macular Degeneration (Phases II, III)